Salvage radical prostatectomy for M0 castration-resistant prostate cancer allows a disease-free window in a significant proportion of men and might cure a minority of patients but entails frequent complications and suboptimal continence. This surgery, whose survival benefits are still to be proven, should be regarded as experimental.

Outcomes of Salvage Radical Prostatectomy for M0 Castration-resistant Recurrent Prostate Cancer: A Reasonable Option in the Era of New Antiandrogen Therapies?

Marra G.
First
;
Calleris G.;Alessio P.;Oderda M.;Gontero P.
Last
2021-01-01

Abstract

Salvage radical prostatectomy for M0 castration-resistant prostate cancer allows a disease-free window in a significant proportion of men and might cure a minority of patients but entails frequent complications and suboptimal continence. This surgery, whose survival benefits are still to be proven, should be regarded as experimental.
2021
7
4
807
811
Castration-resistant prostate cancer; Radiotherapy; Salvage radical prostatectomy; Surgery
Marra G.; Calleris G.; Alessio P.; Oderda M.; Palou J.; Joniau S.; Piechaud T.; Smelzo S.; Morlacco A.; Sharma V.; Tilki D.; Van der Poel H.; Veerman H.; Karnes R.J.; Gontero P.
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2405456920301036-main.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 256.69 kB
Formato Adobe PDF
256.69 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1766140
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact